September 29, 2022 Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting View Article
September 26, 2022 TIPA announces new compostable barrier film with sealing, anti-corrosive properties View Article
September 21, 2022 Mapi Pharma Announces Positive Top-Line Results from GA Depot Phase III Trial for Relapsing forms of Multiple Sclerosis (RMS) View Article
September 20, 2022 Wireless 20|20 and Galooli to Help Service Providers Navigate Energy and Carbon Footprint Reducing Plans Required in New Broadband Funding Submissions View Article
September 19, 2022 PolyPid Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results for D-PLEX₁₀₀ in the Prevention of Surgical Site Infections in Abdominal Surgery View Article
September 19, 2022 Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies View Article
September 12, 2022 Gamida Cell Presents Data Demonstrating the Impact of Transplantation with Omidubicel for Patients with Hematologic Malignancies at 2022 Cord Blood Connect Meeting View Article
September 8, 2022 Alpha Tau Announces the Acceptance in Major Peer-Reviewed Journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of Two Landmark Pre-Clinical Studies Demonstrating Significant Potential Synergies Between the Alpha DaRT Treatment and Standard-of-Care Immunotherapy, Chemotherapy and Anti-Angiogenic Therapy View Article
September 6, 2022 Galooli and Energy Vision Partner to Provide Industry-Leading SaaS Energy Monitoring Solutions View Article
